In clinical studies fasting insulin levels, or the fasting concentrations of C-peptide (a cleavage product of the insulin precursor that is released at equal concentrations to insulin) have been used to examine the links between hyperinsulinemia and cancer. Here, INS is linked to hyperinsulinism.